Copyright © Inderes 2011 - present. All rights reserved.

Swedish Orphan Biovitrum

292,2

 

SEK

 

+4,66 %

Mindre end 1K følgere

SOBI

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Sammenligne
+4,66%
+0,14%
-13,65%
-7,94%
-15,3%
+3,99%
+47,57%
+59,08%
+512,34%

Swedish Orphan Biovitrum operates in the pharmaceutical industry and focuses on the development and distribution of medicines for rare diseases. The company's products are aimed at healthcare institutions and patients with specific medical needs. The business is global with a main presence in Europe, North America and Asia. Swedish Orphan Biovitrum was founded in 1939 and is headquartered in Stockholm, Sweden.

Læs mere
Markedsværdi
104,02 mia. SEK
Aktieomsætning
140,84 mio. SEK
Omsætning
26,03 mia.
EBIT %
21,61 %
P/E
25,7
Udbytteafkast, %
-
Finanskalender
29.4
2025

Delårsrapport Q1'25

8.5
2025

Generalforsamling '25

15.7
2025

Delårsrapport Q2'25

ViserAlle indholdstyper

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.